Now Live — First-Month Free Prescription Program

First-Month Free Prescriptions.
Real Patients. Full Visibility.

Flip Sampling Into ROI with SampliFi.Transform sampling into trackable first-free prescriptions delivered directly to patients. Finally uncover end-to-end visibility to power product adherence, patient acquisition, and operational compliance.

0
B+ Pharma Sampling Market

The pharmaceutical industry invests over $18 billion annually in product sampling — with almost zero accountability.

0
Industry Visibility Today

Once samples leave the shipper, manufacturers have no tracking, no proof of delivery, and no way to measure impact.

0
% Our Tracking Rate

SampliFi tracks every prescription from manufacturer inventory through patient delivery — 100% end-to-end.

0
+ Yrs Regulatory Clearance

Over 2 years of FDA, DEA, and state-level regulatory clearances completed. Audit-ready from day one.

Physician (SampliFi Prescribe) Network Pharmacy FedEx Patient Doorstep

One Platform. Three Stakeholders. Total Visibility.

For Government

Full regulatory compliance baked into every transaction. HIPAA, FDA, DEA, and state-level audit trails generated automatically. Real accountability for public health programs and taxpayer-funded initiatives.

For Manufacturers

End-to-end tracking from inventory through prescribing, fulfillment, and patient delivery. Measure ROI with real data. Eliminate sampling waste. Know exactly where every dollar goes and every prescription lands.

For Patients

First prescription delivered free, direct to your door via FedEx. No insurance hassles. No pharmacy lines. A real prescription — labeled, packaged, and shipped with a follow-up consultation included.

Why We Exist

The $18B Problem Nobody Solved — Until Now

The pharmaceutical industry spends $18 billion annually on product sampling with zero visibility, zero accountability, and zero proof anything reaches patients. Government regulators can't track it. Manufacturers can't measure it. Patients don't benefit from it. SampliFi changes everything by sitting at the intersection of all three stakeholders.

Real Data, Real Results: Measure actual impact on prescribing with granular analytics
No Disruption: Works within existing physician workflows and e-prescribing systems
Full Compliance: Regulatory clearances in place. Audit-ready by design.
Cost Efficiency: Eliminate waste. Consignment model reduces overhead.

Key Advantages

Single Source Oversight

All activities monitored through one licensed, regulated network. No gaps. No silos.

Verified Patient Receipt

Know exactly when and if a patient receives the product. Eliminate sampling black holes.

Audit-Ready Records

Every step tracked and logged automatically. Regulatory documentation at your fingertips.

HCP Engagement Tool

New touchpoint for your sales team. Regain office access and build stronger relationships.

Built on Proven Infrastructure

Powered by industry-proven partners across government, healthcare, and logistics:

ProcareRX FedEx BAT Secure National E-Prescribing Networks
The Industry Problem

Billions Spent. Zero Visibility.

Pharma invests roughly $18B annually in sampling, yet once a sample leaves the shipper, manufacturers have little to no visibility into where it ends up. Samples are typically delivered to a physician's office for handoff to a patient, but without an end-to-end record trail, there's no reliable way to confirm delivery, prevent loss or diversion, or ensure consistent compliance. The result is a system where compliance is high-risk, administrative burden is high-cost, and ROI is nearly impossible to measure. As regulatory scrutiny grows and every commercial dollar is expected to prove impact, the legacy sampling model is fundamentally broken.

Government Blind Spots
Regulators mandate compliance across the pharmaceutical supply chain but lack real-time tools to verify, audit, or track sample distribution at scale.
Manufacturer Black Box
$18B+ spent annually with no record trail once samples leave the shipper. Manufacturers can't prove ROI, can't track delivery, and can't justify spend.
Patients Left Behind
Free samples stockpile in physician offices while patients who need them most never receive them. The current system wasn't designed for patient access.
Fragmented Compliance
FDA, DEA, PDMA, and state-level requirements create a maze of manual, error-prone processes that neither government nor manufacturers can efficiently manage.
No Unified Platform
Government, manufacturers, and patients each operate in isolated silos with different systems, different data, and no shared visibility.

The old model is fundamentally broken. A sample is mailed to a physician for delivery to a patient. There is no accountability once it leaves the shipper's logistics facility. The manufacturer has no way of truly recognizing any concrete impact from that investment. Meanwhile, the industry faces growing compliance requirements, rising administrative costs, and mounting pressure to prove ROI on every dollar spent. The current system cannot deliver visibility, cannot ensure compliance, and cannot measure results. Something had to change.

Our Solution

The Integration Layer for Pharmaceutical Access

SampliFi is the integration layer that connects all three stakeholders through one platform. Government gets automated compliance. Manufacturers get full visibility and ROI data. Patients get their first prescription free, delivered to their door. Think of it as the operating system for pharmaceutical access.

For the first time, every stakeholder — government, manufacturer, and patient — operates on the same platform with shared visibility and accountability.

Real Prescriptions, Not Samples

True no-charge prescriptions entered through existing e-prescribing systems. Labeled, packaged, and delivered like any mail-order Rx. Real medicine, real compliance documentation, real patient access — not another black-box sample program.

End-to-End Data Trail

Every step tracked from manufacturer inventory through prescribing, processing, fulfillment, and delivery. First-time full-cycle visibility. Audit-ready compliance records generated automatically at each stage.

Direct-to-Patient Delivery

Prescriptions shipped directly to patients via FedEx with verified receipt. Follow-up pharmacy consultation included. Patients get real healthcare — not a coupon, not a sample, not a runaround. Government and manufacturers both see the proof.

Compliant by Design

Every step meets or exceeds HIPAA, FDA, DEA, and state-level standards. Over 2 years of regulatory clearances completed. Closed-loop system eliminates unauthorized access and diversion.

Eliminate Waste for Everyone

Consignment inventory eliminates retail reimbursement costs, copay subsidies, and logistics overhead for manufacturers. Government sees reduced program abuse. Patients get medication that would otherwise sit unused in physician offices.

Shared Data, Shared Wins

Customizable reporting for every stakeholder. Manufacturers see ROI and territory analysis. Government sees compliance metrics. Patients see their medication status. One data layer powering three different dashboards.

Process Overview

Six Steps. Manufacturer to Patient. Fully Tracked.

The SampliFi platform operates within existing healthcare infrastructure, connecting government compliance, manufacturer inventory, physician e-prescribing, and patient delivery into one seamless flow. No new systems to learn. No disruption to workflow. Complete integration across all stakeholders.

Step 1: Product Placement

Manufacturer Network Pharmacy

Manufacturers provide consignment stock to the preferred SampliFi network pharmacy. Product ownership remains with the manufacturer — no need to repurchase at retail price. Inventory is tracked, stored, and managed by licensed pharmacy partners.

Step 2: Smart E-Prescribing

Physician E-Prescribing System

Product and pharmacy coding is integrated into major national e-prescribing systems. Instead of asking "Who is your pharmacy?" the physician simply clicks to send the prescription to the SampliFi network pharmacy. Familiar workflow. One-click enrollment for patients.

Step 3: Intelligent Processing

ProcareRX Processing & Verification

ProcareRX verifies it is the patient's first prescription, checks insurance benefits, validates patient and prescriber data, and ensures full federal and state compliance. Processed as a legitimate first fill at no charge. Automatic PDMA reporting. DEA and state tracking integrated.

Step 4: Pharmacy Fulfillment

Network Pharmacy Fulfillment

The network pharmacy fills the prescription with full labeling, patient information sheets, and packaging — exactly like any mail-order prescription. Real prescription. Amber bottle. Proper labeling. Patient-ready for immediate use or follow-up questions.

Step 5: Direct Delivery

FedEx Patient Doorstep

The completed prescription is shipped directly to the patient via FedEx using the manufacturer's account. Patient receipt is verified with tracking. A follow-up consultation call covers medication usage, side effects, and patient questions. Real healthcare engagement.

Step 6: Shared Intelligence

Complete Visibility & ROI Insights

Every stakeholder gets the data they need. Manufacturers see ROI and prescribing patterns. Government gets audit-ready compliance records. Patients see delivery status. Real-time analytics power smarter decisions for everyone in the ecosystem.

Our Foundation

Impossible to Duplicate

Multiple proprietary safeguards. Two years of regulatory clearance. Live beta testing. First-mover advantage is real.

SampliFi is a division of Blockchain Applied Technologies and was developed by industry veterans with deep experience supporting pharmaceutical sales, marketing, and sampling operations. The company's founders previously built and scaled four INC 500 companies, including The Phoenix Companies and The Macaluso Group, delivering data-driven solutions across sample fulfillment, sales enablement, and patient access programs.

Why Choose SampliFi

Built for Government. Built for Pharma. Built for Patients.

Every aspect of SampliFi is designed to serve all three stakeholders simultaneously. Manufacturers get control and ROI. Government gets compliance and transparency. Patients get access and care. One platform delivering value at every level.

True ROI Visibility

Track every step from shipment to patient receipt. Measure impact on prescribing behavior with hard data, not estimates. Know exactly which programs work.

Single Source Oversight

All activities monitored through one centralized system of licensed providers. No gaps. No silos. No fragmented vendor relationships. One dashboard. Complete visibility.

Closed-Loop Data

Every action managed within a single, regulated network. Audit-ready records generated automatically at every stage. Compliance by design, not by chance.

Verified Patient Receipt

Know exactly when and if a patient receives the product. Eliminate the black box of traditional sampling. Real confirmation. Real confidence.

Reduce Financial Waste

Consignment inventory eliminates retail reimbursement costs, copay programs, and traditional logistics overhead. Save tens of thousands per program. Real cost reduction.

Customizable Reporting

Granular reporting at each stage aligned to your KPIs and audit requirements. Geo-coded territory analysis. Export any metric. Build the dashboard you need.

HCP Engagement Renewed

A powerful new touchpoint for manufacturer sales teams. Solve the 'no-see physician' problem while giving government real data on prescribing patterns and patient outcomes.

Patient Adherence Built In

Two free fills place patients firmly on medication. Follow-up pharmacy consultations ensure understanding of treatment. Real healthcare outcomes. Not just samples.

Traditional Sampling vs. SampliFi

Factor Traditional Sampling SampliFi
Sample Visibility No visibility once samples leave the shipper End-to-end tracking, manufacturer to patient
Patient Proof No proof samples ever reach patients Patient receipt verified via FedEx
Compliance Burden High admin costs managing compliance Automated compliance built into the system
Audit Preparation Manual audit prep is resource-intensive Audit-ready records generated automatically
Workflow Integration E-prescribing bottlenecks and delays Seamless e-prescribing integration, one-click
Diversion Risk Diversion and security risks in supply chain Closed-loop prevents unauthorized access
ROI Measurement Impossible to quantify ROI Granular ROI data at every stage
Coverage Gaps Coverage gaps for vacant territories National e-prescribing, no territory gaps

Ready to Join the Future of Pharmaceutical Access?

Whether you're a government agency, pharmaceutical manufacturer, or healthcare organization — SampliFi is built for you. Let's build the future of pharmaceutical access together.

Program Updates & Milestones

February 2026

Program Launch — System Live

SampliFi officially launches with full e-prescribing integration, live beta user cohort, and initial data showing strong patient engagement and compliance metrics.

January 2026

Beta Testing Complete

Successful beta program with leading pharmaceutical manufacturers. All compliance requirements validated. System performance and data accuracy confirmed. Ready for commercial launch.

2024–2025

Regulatory Clearances Secured

FDA, DEA, state pharmacy boards, and federal compliance authorities have cleared SampliFi for full operational deployment. Closed-loop system design meets all security and audit requirements.

Quantitative program results, real-world ROI data, and additional case studies will be published here as they become available.

In the News

January 2026

SampliFi Launches First Real Prescription Program

New system brings end-to-end visibility to pharmaceutical sampling for the first time. Press release and industry coverage.

Read on BioPharma Dive →
December 2025

Regulatory Approval Granted for SampliFi

FDA and DEA provide final clearance for closed-loop pharmaceutical prescription system. Industry experts celebrate breakthrough innovation.

Read on PharmaVoice →

What Our Partners Are Saying

Testimonials Coming Soon

We're collecting feedback from our beta program participants and early adopters. Check back here for real-world impact stories from leading pharmaceutical manufacturers.

Let's Build the Future of Pharmaceutical Access

Whether you represent a government agency, pharmaceutical manufacturer, or healthcare organization — we'd love to show you how SampliFi connects all stakeholders through one integrated platform. Our team is ready to walk through the solution and explore a partnership.

Get In Touch

We'd love to hear from you. Whether you have questions about our First Free Prescription program, want to schedule a demo, or are ready to explore a pilot program, our team is standing by.

Website samplifirx.com
Response Time

We typically respond to inquiries within 24 hours during business days.

SampliFi is a confidential, proprietary system developed under strict regulatory oversight. All inquiries are treated with complete confidentiality.

Start a Conversation